1. Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival. Issue 5 (May 2023) Authors: Dai, W.F.; Habbous, S.; Saluja, R.; Beca, J.M.; Raphael, M.; Arias, J.; Gavura, S.; Earle, C.C.; Biagi, J.J.; Coburn, N.; Chan, K.K.W. Journal: Clinical oncology Issue: Volume 35:Issue 5(2023) Page Start: e303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces. Issue 1 (January 2022) Authors: Beca, J.M.; Dai, W.F.; Pataky, R.E.; Tran, D.; Dvorani, E.; Isaranuwatchai, W.; Peacock, S.; Alvi, R.; Cheung, W.Y.; Earle, C.C.; Gavura, S.; Chan, K.K.W. Journal: Clinical oncology Issue: Volume 34:Issue 1(2022) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗